Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors. Eight cases with clinical and immunological characterization.

International journal of dermatology - 1 Jul 2018

García-Díez Irene, Ivars-Lleó Marta, López-Aventín Daniel, Ishii Norito, Hashimoto Takashi, Iranzo Pilar, Pujol Ramon M, España Agustín, Herrero-Gonzalez Josep E

Abstract excerpt

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors have increasingly been identified as causative agents of bullous pemphigoid. The clinical and immunological characteristics of this pemphigoid variant are still unclear. The objective of our study was to analyze the clinical and immunological features of patients with pemphigoid induced by DPP-4 inhibitors. METHODS: All patients diagnosed with DPP-4...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Autoantigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Collagen Type XVII

Share to Immunoglobulin G

Share to Nitriles

Share to Non-Fibrillar Collagens

Share to Pemphigoid, Bullous

Share to Pyrrolidines

Source

Identifiers

PMID: 29682739
DOI: 10.1111/ijd.14005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors. Eight cases with clinical and immunological characterization.PMID 29682739Read ↗

Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.Semantic proximity Read ↗

Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies.Semantic proximity Read ↗

The impact of lesional inflammatory cellular infiltrate on the phenotype of bullous pemphigoid.Semantic proximity Read ↗

Clinical and immunological profiles of anti-BP230-type bullous pemphigoid: Restriction of epitopes to the C-terminal domain of BP230, shown by novel ELISAs of BP230-domain specific recombinant proteinsSemantic proximity Read ↗

BP180 as the common autoantigen in blistering diseases with different clinical phenotypes.Semantic proximity Read ↗

Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients.Semantic proximity Read ↗

IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review.Semantic proximity Read ↗

Clinical manifestation variability of bullous pemphigoid.Semantic proximity Read ↗

IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid.Semantic proximity Read ↗

Bullous Pemphigoid: Trigger and Predisposing Factors.Semantic proximity Read ↗

Association of Genetic Variants of HLA-DQA1 with Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors.Semantic proximity Read ↗

Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.